Daytime and nighttime effects of brimonidine on IOP and aqueous humor dynamics in participants with ocular hypertension

Shan Fan, Ankit Agrawal, Vikas Gulati, Donna G. Neely, Carol B Toris

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

PURPOSE:: The effects of brimonidine on daytime and nighttime intraocular pressure (IOP) and aqueous humor dynamics were evaluated in volunteers with ocular hypertension (OHT). PATIENTS AND METHODS:: Thirty participants with OHT (58.6±1.7 years old, mean±SEM) were enrolled into this randomized, double-masked, cross-over study. For 6 weeks, participants self-administered 0.2% brimonidine or placebo 3 times daily. During daytime and nighttime visits, measurements included aqueous flow (Fa) by fluorophotometry, outflow facility (C) by tonography, episcleral venous pressure (Pev) by venomanometry, and seated and supine IOP by pneumatonometry. Uveoscleral outflow (U) was calculated mathematically. RESULTS:: When treated with placebo, nighttime supine Pev (11.2±0.25 mm Hg) was higher (P<0.05) compared with daytime seated Pev (10.2±0.25 mm Hg), and Fa and U were significantly reduced at night. Brimonidine significantly lowered seated IOP at 9:00 AM and 11:00 AM, 9:00 PM and 11:00 PM and supine IOP at 9:00 AM and 11:00 AM. Brimonidine increased U at 9 AM and 11 AM (P<0.01) and had no effect on daytime and nighttime Fa, C, or Pev. CONCLUSIONS:: In subjects with OHT, brimonidine treatment for 6 weeks significantly reduces seated IOP during the day by increasing uveoscleral outflow. The lack of IOP effect at night can be explained by failure to overcome a normal nighttime reduction of uveoscleral outflow.

Original languageEnglish (US)
Pages (from-to)276-281
Number of pages6
JournalJournal of Glaucoma
Volume23
Issue number5
DOIs
StatePublished - Jan 1 2014

Fingerprint

Ocular Hypertension
Aqueous Humor
Intraocular Pressure
Fluorophotometry
Placebos
Venous Pressure
Cross-Over Studies
Brimonidine Tartrate
Volunteers

Keywords

  • Aqueous humor dynamics
  • Brimonidine
  • Intraocular pressure
  • Ocular hypertension

ASJC Scopus subject areas

  • Ophthalmology
  • Medicine(all)

Cite this

Daytime and nighttime effects of brimonidine on IOP and aqueous humor dynamics in participants with ocular hypertension. / Fan, Shan; Agrawal, Ankit; Gulati, Vikas; Neely, Donna G.; Toris, Carol B.

In: Journal of Glaucoma, Vol. 23, No. 5, 01.01.2014, p. 276-281.

Research output: Contribution to journalArticle

@article{1f77a2f8a2804b5398398cbc5eaa6725,
title = "Daytime and nighttime effects of brimonidine on IOP and aqueous humor dynamics in participants with ocular hypertension",
abstract = "PURPOSE:: The effects of brimonidine on daytime and nighttime intraocular pressure (IOP) and aqueous humor dynamics were evaluated in volunteers with ocular hypertension (OHT). PATIENTS AND METHODS:: Thirty participants with OHT (58.6±1.7 years old, mean±SEM) were enrolled into this randomized, double-masked, cross-over study. For 6 weeks, participants self-administered 0.2{\%} brimonidine or placebo 3 times daily. During daytime and nighttime visits, measurements included aqueous flow (Fa) by fluorophotometry, outflow facility (C) by tonography, episcleral venous pressure (Pev) by venomanometry, and seated and supine IOP by pneumatonometry. Uveoscleral outflow (U) was calculated mathematically. RESULTS:: When treated with placebo, nighttime supine Pev (11.2±0.25 mm Hg) was higher (P<0.05) compared with daytime seated Pev (10.2±0.25 mm Hg), and Fa and U were significantly reduced at night. Brimonidine significantly lowered seated IOP at 9:00 AM and 11:00 AM, 9:00 PM and 11:00 PM and supine IOP at 9:00 AM and 11:00 AM. Brimonidine increased U at 9 AM and 11 AM (P<0.01) and had no effect on daytime and nighttime Fa, C, or Pev. CONCLUSIONS:: In subjects with OHT, brimonidine treatment for 6 weeks significantly reduces seated IOP during the day by increasing uveoscleral outflow. The lack of IOP effect at night can be explained by failure to overcome a normal nighttime reduction of uveoscleral outflow.",
keywords = "Aqueous humor dynamics, Brimonidine, Intraocular pressure, Ocular hypertension",
author = "Shan Fan and Ankit Agrawal and Vikas Gulati and Neely, {Donna G.} and Toris, {Carol B}",
year = "2014",
month = "1",
day = "1",
doi = "10.1097/IJG.0000000000000051",
language = "English (US)",
volume = "23",
pages = "276--281",
journal = "Journal of Glaucoma",
issn = "1057-0829",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Daytime and nighttime effects of brimonidine on IOP and aqueous humor dynamics in participants with ocular hypertension

AU - Fan, Shan

AU - Agrawal, Ankit

AU - Gulati, Vikas

AU - Neely, Donna G.

AU - Toris, Carol B

PY - 2014/1/1

Y1 - 2014/1/1

N2 - PURPOSE:: The effects of brimonidine on daytime and nighttime intraocular pressure (IOP) and aqueous humor dynamics were evaluated in volunteers with ocular hypertension (OHT). PATIENTS AND METHODS:: Thirty participants with OHT (58.6±1.7 years old, mean±SEM) were enrolled into this randomized, double-masked, cross-over study. For 6 weeks, participants self-administered 0.2% brimonidine or placebo 3 times daily. During daytime and nighttime visits, measurements included aqueous flow (Fa) by fluorophotometry, outflow facility (C) by tonography, episcleral venous pressure (Pev) by venomanometry, and seated and supine IOP by pneumatonometry. Uveoscleral outflow (U) was calculated mathematically. RESULTS:: When treated with placebo, nighttime supine Pev (11.2±0.25 mm Hg) was higher (P<0.05) compared with daytime seated Pev (10.2±0.25 mm Hg), and Fa and U were significantly reduced at night. Brimonidine significantly lowered seated IOP at 9:00 AM and 11:00 AM, 9:00 PM and 11:00 PM and supine IOP at 9:00 AM and 11:00 AM. Brimonidine increased U at 9 AM and 11 AM (P<0.01) and had no effect on daytime and nighttime Fa, C, or Pev. CONCLUSIONS:: In subjects with OHT, brimonidine treatment for 6 weeks significantly reduces seated IOP during the day by increasing uveoscleral outflow. The lack of IOP effect at night can be explained by failure to overcome a normal nighttime reduction of uveoscleral outflow.

AB - PURPOSE:: The effects of brimonidine on daytime and nighttime intraocular pressure (IOP) and aqueous humor dynamics were evaluated in volunteers with ocular hypertension (OHT). PATIENTS AND METHODS:: Thirty participants with OHT (58.6±1.7 years old, mean±SEM) were enrolled into this randomized, double-masked, cross-over study. For 6 weeks, participants self-administered 0.2% brimonidine or placebo 3 times daily. During daytime and nighttime visits, measurements included aqueous flow (Fa) by fluorophotometry, outflow facility (C) by tonography, episcleral venous pressure (Pev) by venomanometry, and seated and supine IOP by pneumatonometry. Uveoscleral outflow (U) was calculated mathematically. RESULTS:: When treated with placebo, nighttime supine Pev (11.2±0.25 mm Hg) was higher (P<0.05) compared with daytime seated Pev (10.2±0.25 mm Hg), and Fa and U were significantly reduced at night. Brimonidine significantly lowered seated IOP at 9:00 AM and 11:00 AM, 9:00 PM and 11:00 PM and supine IOP at 9:00 AM and 11:00 AM. Brimonidine increased U at 9 AM and 11 AM (P<0.01) and had no effect on daytime and nighttime Fa, C, or Pev. CONCLUSIONS:: In subjects with OHT, brimonidine treatment for 6 weeks significantly reduces seated IOP during the day by increasing uveoscleral outflow. The lack of IOP effect at night can be explained by failure to overcome a normal nighttime reduction of uveoscleral outflow.

KW - Aqueous humor dynamics

KW - Brimonidine

KW - Intraocular pressure

KW - Ocular hypertension

UR - http://www.scopus.com/inward/record.url?scp=84902162175&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902162175&partnerID=8YFLogxK

U2 - 10.1097/IJG.0000000000000051

DO - 10.1097/IJG.0000000000000051

M3 - Article

C2 - 24886701

AN - SCOPUS:84902162175

VL - 23

SP - 276

EP - 281

JO - Journal of Glaucoma

JF - Journal of Glaucoma

SN - 1057-0829

IS - 5

ER -